Articles

Clofarabine increases the eradication of minimal residual disease of primary Bprecursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome

Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty Duesseldorf, Duesseldorf
Department of Pediatric Hematology/Oncology, University Hospital Bonn, Bonn
Department of Pediatric Hematology/Oncology, University Hospital Mainz, Mainz
Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich
Department of Pediatric Hematology and Oncology, Helios Hospital, Krefeld
Department of Pediatric Hematology and Oncology, Protestant Hospital of Bethel Foundation, Bielefeld
Department of Pediatric Hematology and Oncology, Hospital Bremen-Mitte
Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich
Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children’s Cancer Center Hamburg, Germany; Bioinformatics Core Unit, University Medical Center Hamburg
Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover
Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children’s Cancer Center Hamburg
Haematologica Early view Aug 5, 2021 https://doi.org/10.3324/haematol.2021.279357